Pyxis Oncology, Inc.
PYXS
$1.70
$0.010.59%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -18.11M | -22.00M | -18.35M | -21.16M |
| Total Depreciation and Amortization | -- | 2.90M | 527.00K | 535.00K | 552.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 1.93M | 2.75M | 2.32M | 2.67M |
| Change in Net Operating Assets | -- | 2.86M | 5.45M | -1.77M | -4.60M |
| Cash from Operations | -- | -10.43M | -13.28M | -17.26M | -22.54M |
| Capital Expenditure | -- | 0.00 | -9.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 16.26M | 11.48M | 15.30M | 15.82M |
| Cash from Investing | -- | 16.26M | 11.47M | 15.30M | 15.82M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 740.00K | 0.00 | 0.00 | 2.00K |
| Repurchase of Common Stock | -- | -71.00K | -8.00K | -67.00K | -2.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 669.00K | -8.00K | -67.00K | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 6.50M | -1.81M | -2.03M | -6.71M |